Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lilly Sets Up First China Venture Fund

This article was originally published in PharmAsia News

Executive Summary

After its initial investment in BioVeda China, Eli Lilly Asia Capital Fund is set to enter the second phase of directly investing in the pharmaceutical sector. According to officials, the fund, which targets China as a major investment market, is focusing on life sciences, medical and diagnostic devices, and health care. Project collaboration with universities and academic institutions in key coastal cities will get an initial injection of $1-5 million and up to a total of $10-15 million each. GSK is considering setting up its own venture capital in China if suitable projects are available. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts